International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 2 (March-April 2026) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.

Clinical Evaluation Of Katibasti with Agnitaila in Gridhrasi (Sciatica) – A Case Series

Author(s) Dr. ALLAPPA S KUMBAR, Dr. PRASHANTH KUMAR, Dr. NITIN V, Prof. Dr. BASAVARAJA G SARAGANACHARI
Country India
Abstract Gridhrasi, classified as a Vataja Nanatmaja Vyadhi, closely resembles Sciatica in modern science and presents with symptoms such as radiating low back pain, Stambha, Ruk, Toda, and Spandana. Though primarily Vata-dominant, Kapha involvement is also noted in certain cases, leading to subtypes—Vataja and Vatakaphaja Gridhrasi. Snigdha Swedana in the form of Katibasti is a widely practiced therapeutic procedure for Vata-related conditions of the lower back. The present study, titled "Clinical Evaluation Of Katibasti With Agnitaila In Gridhrasi (Sciatica)", aimed to evaluate the efficacy of Agnitaila in managing Gridhrasi.
Objectives:
Primary: To see the therapeutic efficacy of Katibasti with Agnitaila through Clinical Gradings, VAS Scale, SLR Test & ODI Questionnaire method.
Secondary: To enhance the quality of life by reducing the pain, dependency & improving the functionality.
Methodology:
A total of 15 patients were selected and Katibasti was administered for 45 minutes daily for 10 days using Agnitaila
Observations & Interpretation:
The highest incidence was observed in the 36–45 age group (60%), with a slightly higher prevalence in males (53.3%). The majority of patients were IT professionals and homemakers, with Vataja Gridhrasi being more common (70%). Majority of the patients were having <1 year duration of illness.

Discussion & Results:
Statistical analysis within the groups showed significant improvement in all parameters, with Agnitaila showing better results in relieving Ruk, Stambha and Toda, slightly less effective in reducing Spandana and Gaurava.
Conclusion:
The findings suggest that Katibasti with Agnitaila is a safe and effective treatment for Gridhrasi, providing significant symptomatic relief without worsening Kaphaja symptoms.
Keywords Gridhrasi; Swedana; Katibasti; Agnitaila
Field Medical / Pharmacy
Published In Volume 8, Issue 1, January-February 2026
Published On 2026-02-13

Share this